Post-earnings recap
Reported
Thu, Apr 25, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
Biogen's earnings report showed a strong performance in EPS, exceeding expectations significantly. This positive surprise led to a 4.76% increase in the stock price, reflecting investor confidence despite the lack of revenue data and management commentary. The absence of guidance may leave some investors cautious about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.97 | N/A | +23.36% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—